产品封面图
文献支持

SIGMA SML2270-5MG FRAX486 1232

030-35-1
收藏
  • ¥633
  • Sigma-Aldrich
  • 进口
  • SML2270-5MG
  • 2025年07月15日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      −20°C

    • 保质期

      根据瓶身LOT号查询

    • 英文名

      FRAX486

    • 库存

      有现货

    • 供应商

      浙江羽翔生物科技有限公司

    • CAS号

      1232030-35-1

    • 规格

      5MG

    属性

    方案

    ≥98% (HPLC)

    表单

    powder

    颜色

    white to beige

    溶解性

    DMSO: 2 mg/mL, clear

    储存温度

    −20°C

    SMILES字符串

    FC1=CC(NC2=NC(N3CC)=C(C=N2)C=C(C4=CC=C(C=C4Cl)Cl)C3=O)=CC=C1N5CCNCC5

    InChI

    1S/C25H23Cl2FN6O/c1-2-34-23-15(11-19(24(34)35)18-5-3-16(26)12-20(18)27)14-30-25(32-23)31-17-4-6-22(21(28)13-17)33-9-7-29-8-10-33/h3-6,11-14,29H,2,7-10H2,1H3,(H,30,31,32)

    InChI key

    DHKFOIHIUYFSOF-UHFFFAOYSA-N

    生化/生理作用

    FRAX486 is a potent, group I-selective p21-activated kinase (PAK) inhibitor (PAK1/2/3 IC50 = 8.25/39.5/55.3 nM; group II PAK4 IC50 = 779 nM). FRAX486 effectively inhibits PAK-mediated PKD1 Ser203 phosphorylation and PAK1/2 Ser144/141 autophosphorylation upon angiotensin II (ANGII) stimulation of rat IEC-18 cells (IC50 ∼0.5 μM) and exhibits in vivo efficacy in rescuing the autism-like phenotypes among Fmr1 knockout fragile syndrome (FXS) mice (20 mg/kg s.c.) as well as in ameliorating schizophrenia-associated dendritic spine deterioration among Disc1 knockdown mice (10 μg/g or 10 mg/kg i.p.) with good pharmacokinetic properties and blood–brain barrier (BBB) permeability.
    Potent group I-selective p21-activated kinase (PAK1/2/3) inhibitor with in vivo efficacy in murine models of Fragile X syndrome and schizophrenia.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    Protein kinase D1 (PKD1) phosphorylation on Ser203 by type I p21-activated kinase (PAK) regulates PKD1 localization.

    The Journal of biological chemistry (2017-04-15)
    Jen-Kuan Chang, Yang Ni, Liang Han, James Sinnett-Smith, Rodrigo Jacamo, Osvaldo Rey, Steven H Young, Enrique Rozengurt
    PMID28408623
    摘要

    Although PKC-mediated phosphorylation of protein kinase D1 (PKD1) has been extensively characterized, little is known about PKD1 regulation by other upstream kinases. Here we report that stimulation of epithelial or fibroblastic cells with G protein-coupled receptor agonists, including angiotensin II or bombesin, induced rapid and persistent PKD1 phosphorylation at Ser203, a highly conserved residue located within the PKD1 N-terminal domain. Exposure to PKD or PKC family inhibitors did not prevent PKD1 phosphorylation at Ser203, indicating that it is not mediated by autophosphorylation. In contrast, several lines of evidence indicated that the phosphorylation of PKD1 at Ser203 is mediated by kinases of the class I PAK subfamily, specifically 1) exposing cells to four structurally unrelated PAK inhibitors (PF-3758309, FRAX486, FRAX597, and IPA-3) that act via different mechanisms abrogated PKD1 phosphorylation at Ser203, 2) siRNA-mediated knockdown of PAK1 and PAK2 in IEC-18 and Swiss 3T3 cells blunted PKD1 phosphorylation at Ser203, 3) phosphorylation of Ser203 markedly increased in vitro when recombinant PKD1 was incubated with either PAK1 or PAK2 in the presence of ATP. PAK inhibitors did not interfere with G protein-coupled receptor activation-induced rapid translocation of PKD1 to the plasma membrane but strikingly prevented the dissociation of PKD1 from the plasma membrane and blunted the phosphorylation of nuclear targets, including class IIa histone deacetylases. We conclude that PAK-mediated phosphorylation of PKD1 at Ser203 triggers its membrane dissociation and subsequent entry into the nucleus, thereby regulating the phosphorylation of PKD1 nuclear targets, including class IIa histone deacetylases.

    相关实验
    • Transcription, Translation of S35-Radiolabelled Protein and Binding to GST-Fused Proteins or Antibodies (IP)

      GEX fusion proteins or antisera Combine 15ul lysate with 5ul fused protein (2mg/ml) or 5ul antisera in 0.5ml PLC basic lysis buffer (see Appendix) Incubate ice 1 hr Swell 2mg Glutathione agarose beads (Sigma G-4510) or 2.5mg

    • 【共享】小论如何避免RNA提取时28s上方会多一条带

      2 1.2ml Trizol, lane3 1.5ml Trizol,lane4 2mlTrizol 以上用0.2倍体积氯仿,只用Trizol抽提一次 lane5 1ml Trizol,0.35体积氯仿,抽提一次 lane6 1ml Trizol, 0.35体积氯仿,抽提两次 lane7 1ml Trizol, 0.20体积氯仿,抽提两次 lane8 2ml Trizol,等体积氯仿 其中lane5为常规提取方法。 如果1-5有杂带,,67没有,说明是脑组织本身蛋白量和hnRNA过多

    • Single tube confirmation PCR protocol

      (200mg/l). - Incubate at 30°C for two to three days. *This step reduces background by eliminating aborted transformants.   2. Zymolyase treatment - Transfer a small portion of a well-isolated colony (~1 mm) into 50 µl solution

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥829
    嘉兴亦高医疗器械有限公司
    2025年10月20日询价
    ¥576
    上海源叶生物科技有限公司
    2025年10月29日询价
    询价
    江西江蓝纯生物试剂有限公司
    2025年05月23日询价
    ¥4000
    上海机纯实业有限公司
    2025年07月15日询价
    ¥99
    上海鹿森生物工程有限公司
    2025年07月08日询价
    文献支持
    SIGMA SML2270-5MG FRAX486 1232030-35-1
    ¥633